Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 40% ± 18% | |
oligodendrocyte | 11 studies | 30% ± 10% | |
endothelial cell | 10 studies | 28% ± 16% | |
oligodendrocyte precursor cell | 8 studies | 35% ± 16% | |
glutamatergic neuron | 7 studies | 37% ± 21% | |
microglial cell | 7 studies | 28% ± 13% | |
adipocyte | 7 studies | 32% ± 10% | |
GABAergic neuron | 6 studies | 43% ± 16% | |
fibroblast | 6 studies | 25% ± 13% | |
amacrine cell | 5 studies | 41% ± 13% | |
retinal rod cell | 5 studies | 38% ± 17% | |
retina horizontal cell | 5 studies | 51% ± 20% | |
Mueller cell | 5 studies | 53% ± 15% | |
retinal cone cell | 5 studies | 38% ± 15% | |
smooth muscle cell | 5 studies | 25% ± 10% | |
macrophage | 5 studies | 26% ± 6% | |
retinal bipolar neuron | 4 studies | 51% ± 20% | |
retinal pigment epithelial cell | 4 studies | 37% ± 18% | |
retinal ganglion cell | 4 studies | 30% ± 15% | |
interneuron | 4 studies | 44% ± 24% | |
ON-bipolar cell | 3 studies | 57% ± 30% | |
rod bipolar cell | 3 studies | 70% ± 11% | |
endothelial cell of vascular tree | 3 studies | 21% ± 5% | |
hepatocyte | 3 studies | 32% ± 10% | |
ependymal cell | 3 studies | 31% ± 12% | |
pericyte | 3 studies | 24% ± 6% | |
granule cell | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3566.07 | 2634 / 2642 | 95% | 15.40 | 673 / 705 |
prostate | 97% | 2466.77 | 237 / 245 | 96% | 11.99 | 481 / 502 |
thymus | 96% | 2485.39 | 624 / 653 | 97% | 21.08 | 584 / 605 |
ovary | 99% | 2739.19 | 179 / 180 | 89% | 9.55 | 382 / 430 |
breast | 95% | 2220.39 | 438 / 459 | 92% | 12.33 | 1028 / 1118 |
esophagus | 98% | 3183.61 | 1409 / 1445 | 89% | 13.48 | 162 / 183 |
adrenal gland | 94% | 1505.93 | 242 / 258 | 89% | 13.61 | 205 / 230 |
uterus | 100% | 2780.09 | 170 / 170 | 82% | 12.40 | 377 / 459 |
kidney | 90% | 1272.36 | 80 / 89 | 90% | 10.84 | 812 / 901 |
pancreas | 81% | 985.51 | 267 / 328 | 92% | 10.43 | 163 / 178 |
lung | 92% | 1621.42 | 529 / 578 | 81% | 8.72 | 939 / 1155 |
skin | 75% | 2045.38 | 1349 / 1809 | 89% | 9.56 | 418 / 472 |
liver | 91% | 1980.91 | 206 / 226 | 69% | 5.48 | 279 / 406 |
bladder | 100% | 2354.86 | 21 / 21 | 57% | 4.71 | 289 / 504 |
stomach | 93% | 1716.83 | 334 / 359 | 59% | 5.51 | 170 / 286 |
intestine | 89% | 2853.25 | 860 / 966 | 46% | 3.68 | 241 / 527 |
blood vessel | 96% | 2417.87 | 1281 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 19.69 | 42 / 45 |
adipose | 93% | 2147.96 | 1121 / 1204 | 0% | 0 | 0 / 0 |
muscle | 89% | 1448.48 | 714 / 803 | 0% | 0 | 0 / 0 |
heart | 82% | 1119.67 | 706 / 861 | 0% | 0 | 0 / 0 |
spleen | 74% | 712.23 | 178 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 4.90 | 57 / 80 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.42 | 7 / 29 |
peripheral blood | 7% | 73.41 | 69 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045187 | Biological process | regulation of circadian sleep/wake cycle, sleep |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0050821 | Biological process | protein stabilization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019900 | Molecular function | kinase binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
Gene name | PER3 |
Protein name | PER3 protein (Period circadian regulator 3) PER3 protein Period circadian protein homolog 3 (hPER3) (Cell growth-inhibiting gene 13 protein) (Circadian clock protein PERIOD 3) Period circadian regulator 3 Period 3 |
Synonyms | GIG13 |
Description | FUNCTION: Originally described as a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1, NR1D2, RORA, RORB and RORG, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. Has a redundant role with the other PER proteins PER1 and PER2 and is not essential for the circadian rhythms maintenance. In contrast, plays an important role in sleep-wake timing and sleep homeostasis probably through the transcriptional regulation of sleep homeostasis-related genes, without influencing circadian parameters. Can bind heme. . |
Accessions | Q8TAR6 A6H8X0 Q2TAB4 ENST00000377541.5 P56645 A0A087WV69 ENST00000614998.4 A2I2N5 ENST00000361923.2 [P56645-1] ENST00000613533.4 [P56645-2] ENST00000377532.8 [P56645-2] |